Catégorie : Concentration-fusions

31 août 2010 Guillaume de DURAT 1 Comments

Sanofi-Genzyme. Pipeline war..

From FT news.. Sanofi-Aventis’ all but hostile $18.5bn bid for Genzyme elicited the usual rejection drivel. The troubled US biotech believes it is undervalued by…